Cargando…

Alleviation Effects of Microbial Metabolites from Resveratrol on Non-Alcoholic Fatty Liver Disease

Resveratrol (RSV), a polyphenolic stilbene, has been widely studied for its protective effects against non-alcoholic fatty liver disease (NAFLD) by modulating intestinal microbiota. The microbial metabolites after RSV supplement would contribute to the bioeffects of RSV, while their impacts on NAFLD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Jingling, Wang, Pan, Cui, Yifan, Hu, Xiaosong, Chen, Fang, Ma, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818778/ https://www.ncbi.nlm.nih.gov/pubmed/36613310 http://dx.doi.org/10.3390/foods12010094

Ejemplares similares

Microbial metabolites in non-alcoholic fatty liver disease
por: Zhou, Da, et al.
Publicado: (2019)

Effect of resveratrol on non-alcoholic fatty liver disease
por: Theodotou, Marios, et al.
Publicado: (2019)

Polydatin, A Glycoside of Resveratrol, Is Better Than Resveratrol in Alleviating Non-alcoholic Fatty Liver Disease in Mice Fed a High-Fructose Diet
por: Zhao, Guangshan, et al.
Publicado: (2022)

Protective Effects of Hydroxyphenyl Propionic Acids on Lipid Metabolism and Gut Microbiota in Mice Fed a High-Fat Diet
por: Guo, Jingling, et al.
Publicado: (2023)

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
por: Du, Fan, et al.
Publicado: (2021)

Interventions for non-alcoholic liver disease: a gut microbial metabolites perspective
por: Guo, Jin, et al.
Publicado: (2022)

Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy
por: Wan, Shuqian, et al.
Publicado: (2018)

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
por: Vallianou, Natalia, et al.
Publicado: (2021)

New Mechanisms of Bromelain in Alleviating Non-Alcoholic Fatty Liver Disease-Induced Deregulation of Blood Coagulation
por: Hu, Po-An, et al.
Publicado: (2022)

Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
por: Park, Ji-Won, et al.
Publicado: (2021)

Dietary Platycodon grandiflorus Attenuates Hepatic Insulin Resistance and Oxidative Stress in High-Fat-Diet Induced Non-Alcoholic Fatty Liver Disease
por: Ke, Weixin, et al.
Publicado: (2020)

Correction to ‘Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy’
por: Wan, S., et al.
Publicado: (2019)

Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease—A Meta-Analysis
por: Jakubczyk, Karolina, et al.
Publicado: (2020)

Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats
por: Shen, Shu-Hua, et al.
Publicado: (2020)

Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
por: Zhou, Jin, et al.
Publicado: (2021)

Bamboo shoot dietary fiber alleviates gut microbiota dysbiosis and modulates liver fatty acid metabolism in mice with high-fat diet-induced obesity
por: Zhou, Xiaolu, et al.
Publicado: (2023)

Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae
por: Gan, Lin, et al.
Publicado: (2023)

Ufmylation on UFBP1 alleviates non-alcoholic fatty liver disease by modulating hepatic endoplasmic reticulum stress
por: Mao, Ziming, et al.
Publicado: (2023)

Nuclear Receptor-Mediated Alleviation of Alcoholic Fatty Liver by Polyphenols Contained in Alcoholic Beverages
por: Yao, Ruiqing, et al.
Publicado: (2014)

Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials
por: Zhang, Chongyang, et al.
Publicado: (2016)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Association of serum methionine metabolites with non-alcoholic fatty liver disease: a cross-sectional study
por: Tang, Yi, et al.
Publicado: (2022)

Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production
por: Ma, Zhenhua, et al.
Publicado: (2017)

Cordyceps militaris alleviates non-alcoholic fatty liver disease in ob/ob mice
por: Choi, Ha-Neul, et al.
Publicado: (2014)

Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease
por: Liang, Xiao-yu, et al.
Publicado: (2021)

Vitamin D alleviates non-alcoholic fatty liver disease via restoring gut microbiota and metabolism
por: Zhang, Xiao-Lei, et al.
Publicado: (2023)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
por: Yang, Sa, et al.
Publicado: (2022)

Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis
por: Pan, Xiongfeng, et al.
Publicado: (2020)

Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice
por: Kang, Kai, et al.
Publicado: (2021)

Schisantherin A alleviates non-alcoholic fatty liver disease by restoring intestinal barrier function
por: Yu, Shenglan, et al.
Publicado: (2022)

The Regulatory Effects of Citrus Peel Powder on Liver Metabolites and Gut Flora in Mice with Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Hu, Meiyi, et al.
Publicado: (2021)

Resveratrol inhibits nonalcoholic fatty liver disease in rats
por: Bujanda, Luis, et al.
Publicado: (2008)

Fecal Metagenomics and Metabolomics Identifying Microbial Signatures in Non-Alcoholic Fatty Liver Disease
por: Pekkala, Satu
Publicado: (2023)

Probiotics for Alleviating Alcoholic Liver Injury
por: Gu, Zelin, et al.
Publicado: (2019)

Limonin Alleviates Non-alcoholic Fatty Liver Disease by Reducing Lipid Accumulation, Suppressing Inflammation and Oxidative Stress
por: Li, Yunjia, et al.
Publicado: (2022)

Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo
por: Yin, Guoliang, et al.
Publicado: (2022)

Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Ji, Yun, et al.
Publicado: (2019)

Fu brick tea alleviates high fat induced non-alcoholic fatty liver disease by remodeling the gut microbiota and liver metabolism
por: Tang, Yan, et al.
Publicado: (2022)

Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome
por: Chen, Yong, et al.
Publicado: (2022)

Herbal Extracts and Natural Products in Alleviating Non-alcoholic Fatty Liver Disease via Activating Autophagy
por: Zhang, Li, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3ki42senccirbbfqp1jrsaunle